These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30457418)

  • 1. Influence of protamine shell on nanoemulsions as a carrier for cyclosporine-A skin delivery.
    Alvarez-Figueroa MJ; Abarca-Riquelme JM; González-Aramundiz JV
    Pharm Dev Technol; 2019 Jun; 24(5):630-638. PubMed ID: 30457418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of Chitosan Nanocapsules with Compritol 888 ATO® for Imiquimod Transdermal Administration. Evaluation of Their Skin Absorption by Raman Microscopy.
    Alvarez-Figueroa MJ; Narváez-Araya D; Armijo-Escalona N; Carrasco-Flores EA; González-Aramundiz JV
    Pharm Res; 2020 Sep; 37(10):195. PubMed ID: 32944793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, and
    Walunj M; Doppalapudi S; Bulbake U; Khan W
    J Liposome Res; 2020 Mar; 30(1):68-79. PubMed ID: 30897993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of physicochemical properties of nanocolloidal carrier loaded with cyclosporine for topical treatment of psoriasis: in vitro diffusion and in vivo hydrating action.
    Musa SH; Basri M; Fard Masoumi HR; Shamsudin N; Salim N
    Int J Nanomedicine; 2017; 12():2427-2441. PubMed ID: 28405165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
    Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK
    Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid self-nanoemulsifying cyclosporine A pellets prepared by fluid-bed coating: stability and bioavailability study.
    Lei Y; Qi J; Nie S; Hu F; Pan W; Lu Y; Wu W
    J Biomed Nanotechnol; 2012 Jun; 8(3):515-21. PubMed ID: 22764422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways.
    Lapteva M; Santer V; Mondon K; Patmanidis I; Chiriano G; Scapozza L; Gurny R; Möller M; Kalia YN
    J Control Release; 2014 Dec; 196():9-18. PubMed ID: 25278258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of zeta potential of innovative lipid nanocapsules on triamcinolone transdermal delivery.
    Alvarez-Figueroa MJ; Alarcón DA; González-Aramúndiz JV
    Drug Deliv Transl Res; 2022 Nov; 12(11):2740-2750. PubMed ID: 35284985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine.
    Park MJ; Balakrishnan P; Yang SG
    Int J Pharm; 2013 Jan; 441(1-2):757-64. PubMed ID: 23089581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of protamine nanocapsules as antigen delivery carriers.
    González-Aramundiz JV; Presas E; Dalmau-Mena I; Martínez-Pulgarín S; Alonso C; Escribano JM; Alonso MJ; Csaba NS
    J Control Release; 2017 Jan; 245():62-69. PubMed ID: 27856263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of transdermal delivery of Cyclosporine A using plasma discharges.
    Kristof J; Miyamoto H; Tran AN; Blajan M; Shimizu K
    Biointerphases; 2017 May; 12(2):02B402. PubMed ID: 28476092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic vesicles: a novel topical drug delivery system.
    Foldvari M
    J Biomed Nanotechnol; 2010 Oct; 6(5):543-57. PubMed ID: 21329047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyamide nanocapsules and nano-emulsions containing Parsol® MCX and Parsol® 1789: in vitro release, ex vivo skin penetration and photo-stability studies.
    Hanno I; Anselmi C; Bouchemal K
    Pharm Res; 2012 Feb; 29(2):559-73. PubMed ID: 21938595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach.
    Thwala LN; Beloqui A; Csaba NS; González-Touceda D; Tovar S; Dieguez C; Alonso MJ; Préat V
    J Control Release; 2016 Dec; 243():109-120. PubMed ID: 27720993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical delivery of Cyclosporine A into the skin using SPACE-peptide.
    Chen M; Kumar S; Anselmo AC; Gupta V; Slee DH; Muraski JA; Mitragotri S
    J Control Release; 2015 Feb; 199():190-7. PubMed ID: 25481447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K1-loaded lipid-core nanocapsules: physicochemical characterization and in vitro skin permeation.
    da Silva AL; Contri RV; Jornada DS; Pohlmann AR; Guterres SS
    Skin Res Technol; 2013 Feb; 19(1):e223-30. PubMed ID: 22672012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal drug delivery: from micro to nano.
    Pegoraro C; MacNeil S; Battaglia G
    Nanoscale; 2012 Mar; 4(6):1881-94. PubMed ID: 22334401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraflexible lipid vesicles allow topical absorption of cyclosporin A.
    Carreras JJ; Tapia-Ramirez WE; Sala A; Guillot AJ; Garrigues TM; Melero A
    Drug Deliv Transl Res; 2020 Apr; 10(2):486-497. PubMed ID: 31811620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of in vivo efficacy of topical formulations containing soybean extract.
    Georgetti SR; Casagrande R; Verri WA; Lopez RF; Fonseca MJ
    Int J Pharm; 2008 Mar; 352(1-2):189-96. PubMed ID: 18079076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity.
    Guada M; Sebastián V; Irusta S; Feijoó E; Dios-Viéitez Mdel C; Blanco-Prieto MJ
    Int J Nanomedicine; 2015; 10():6541-53. PubMed ID: 26527872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.